This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://dx.doi.org/10.3899/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q93231037
rdf:type
wikibase:Item
schema:description
scientific article published on 25 April 2020 наукова стаття, опублікована 25 квітня 2020 article scientifique publié en 2020 artículu científicu espublizáu n'abril de 2020 wetenschappelijk artikel
p:P577
wds:Q93231037-D2034481-11BE-4E8B-A573-147A8445D813
wdt:P577
2020-04-25T00:00:00Z
p:P407
wds:Q93231037-1E2CA088-615C-4196-869F-A6474F37882B
wdt:P407
wd:Q1860
p:P2093
wds:Q93231037-62B7C6C3-404D-44C6-B1CC-4D8B79D3C636 wds:Q93231037-4467666B-ECC8-434B-BE6C-9490AB3A5218 wds:Q93231037-3D3C7908-8AFD-418F-AF1E-EA2634D5AF91 wds:Q93231037-199DD202-6038-4A7F-B066-A069E9B48C86 wds:Q93231037-E84E3C5E-0478-4F1D-9069-8D2323E6D5F4 wds:Q93231037-E595F710-7EF3-4C9E-8F42-2EDA6FA4CEDE
wdt:P2093
Micol Romano Stefania Costi Pediatric Rheumatology Group of the Milan Area Giovanni Filocamo Francesca Minoia Simone Carbogno
rdfs:label
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
skos:prefLabel
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
schema:name
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
p:P50
wds:Q93231037-78E9D45E-E126-406B-945B-DBF910172F8A
wdt:P50
wd:Q88307472
p:P1476
wds:Q93231037-991CEA24-6B8B-40FB-AEA5-9255A7904F76
wdt:P1476
Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs
p:P31
wds:Q93231037-6E2F8071-7761-4E7A-8DEE-93FDA198E119
wdt:P31
wd:Q13442814
p:P921
wds:Q93231037-783C459C-7B4D-4C0D-B79F-68B219E1A833
wdt:P921
wd:Q82069695
p:P698
wds:Q93231037-910CD722-FA36-40D1-AC9C-387F4C8CC639
wdtn:P698
n9:32335512
wdt:P698
32335512
p:P1433
wds:Q93231037-4AB09648-DD08-4AA7-B882-843FF472AAF4
wdt:P1433
wd:Q7743623
p:P356
wds:Q93231037-0BB28099-6706-48F7-8E9B-F3AE475600C6
wdtn:P356
n12:JRHEUM.200483
wdt:P356
10.3899/JRHEUM.200483
p:P6179
wds:Q93231037-19F1C72C-3694-4F2A-974F-D0E16D9D7416
wdt:P6179
1127143779